Izotropic Corporation reported the Company has successfully relocated IzoView and associated components and completed the transition of all major medical device engineering and product development operations to California.
Further to the Company's prior announcement, the move to relocate commercial development of IzoView to Sacramento, CA was made to help accelerate testing and optimization of the device as the Company prepares for its upcoming clinical study and submission for market authorization in the U.S.